Health and Human Services Secretary Robert F. Kennedy Jr., confirmed by the Senate in February 2025, continues to lead the department amid ongoing controversies, as evidenced by his April 2026 testimonies before the Senate HELP Committee and House Ways and Means on the FY 2026 HHS budget request, where he defended staffing cuts and agency reforms. Trader consensus at 70.5% for "No" reflects his entrenched position over a year into the term, with no public statements, official announcements, or confirmed resignation plans despite recent high-profile departures—including chief spokesperson's abrupt exit on May 14 over FDA flavored e-cigarette policy disagreements and FDA Commissioner Marty Makary's ouster earlier in May. Staff shakeups signal internal tensions, but absent escalation like a no-confidence push or scandal, markets price sustained tenure through December 31, 2026, ahead of midterm election pressures.